Why does the octopus-MDMA study matter for how we understand psychedelic science? 

Key Takeaways:

•The octopus-MDMA study matters because it suggests that some social effects of MDMA may depend on ancient molecular systems, not just human brain anatomy.

•The study found that MDMA increased social approach in Octopus bimaculoides, a species that is usually solitary.

•Gül Dölen’s later commentary argues that the study challenges research models that focus too heavily on brain scans and named brain networks.

•The finding does not mean octopuses have human-like experiences, but it does show that very different nervous systems can share similar molecular “locks.”

•For therapy, the larger lesson is that psychedelic drugs are not the therapy itself; they may create a window in which therapy, context, and integration matter. 

Why does the octopus-MDMA study matter?

The octopus-MDMA study matters because it shifts the question from “Which human brain region explains psychedelic effects?” to “What molecular systems make these effects possible?” In the study, octopuses exposed to MDMA spent more time near another octopus, even though octopuses are usually solitary animals (1).

I have always found octopuses fascinating. They can feel almost like aliens living here on Earth. They solve problems, change color, squeeze through tiny spaces, and seem to move through the world with a very different kind of intelligence. That is part of what makes this study so interesting. If a creature this different from us responds to MDMA in a socially meaningful way, then psychedelic science may need to look deeper than human brain maps alone. This article explains what the study found, why Gül Dölen’s later commentary matters, and how this research challenges a common way of thinking about psychedelics, the brain, and therapy. 

What did the researchers actually do?

Researchers compared the human serotonin transporter with the octopus version, then tested whether MDMA changed octopus social behavior. They found that a key MDMA binding region was highly conserved, and they observed that MDMA increased social approach in Octopus bimaculoides (1).

The study had two main parts. First, Edsinger and Dölen studied the octopus genome. They looked for genes related to SLC6A4, the gene that encodes the serotonin transporter, also called SERT. In humans, SERT is one of the main molecular targets involved in MDMA’s effects. The researchers found octopus versions of this gene and reported that the MDMA and serotonin binding region was highly conserved (1).

Second, they created a three-chamber social test. An octopus could move between chambers that contained a novel object, another octopus, or an empty center area. Before MDMA, the octopuses tended to avoid a male social stimulus. After MDMA exposure, they spent more time in the social chamber (1). 

Did MDMA make octopuses “social” in the same way humans are social?

No. The study does not prove that octopuses felt human-like empathy, love, or connection. It shows that MDMA changed their social approach behavior in a measurable way, and that this change may involve a serotonin-related molecular target that is shared across very distant species (1).

This distinction matters. It is tempting to turn the study into a cute headline about octopuses becoming cuddly. The actual science is more careful and more powerful. The researchers did not claim to know what an octopus felt. Instead, they measured what the animals did.

After MDMA, the octopuses spent more time near the other octopus. The researchers also noted a change in the quality of contact. Under control conditions, contact was often limited. After MDMA, the animals showed more extensive body contact that appeared exploratory rather than aggressive (1). 

Why does Gül Dölen say the study challenges brain-scan thinking?

Dölen argues that the octopus study points toward molecular mechanisms that brain-scan-centered research can miss. In her 2026 Tricycle Day interview, she said fMRI does not have the spatial or temporal sensitivity to detect the molecular changes she believes may drive psychedelic effects (2).

This is an important point. A great deal of public psychedelic discussion focuses on visible brain networks, such as the default mode network. Those models can be useful, but they are still anatomy-based models. They are shaped by the human brain and its evolutionary path. 

Octopuses create a serious challenge for that frame. They do not have the same brain regions that human imaging studies often focus on. Yet Dölen’s commentary makes the molecular point clearly:

“The brain anatomy lights up differently across species, but the molecule finds the same lock.” — Gül Dölen, quoted in Tricycle Day (2)

That line captures why the octopus study matters. It asks us to look below the level of named brain regions and pay attention to the molecular tools that evolution may have preserved. 

What does “the molecule finds the same lock” mean?

It means that MDMA may act on a similar molecular target even in animals with very different brains. Humans and octopuses do not share the same brain anatomy, but the MDMA binding site in the serotonin transporter appears to be remarkably similar (1, 2).

This does not make octopuses tiny humans. It also does not make humans simple machines. Instead, it suggests that evolution can reuse molecular systems in very different bodies and brains.

A helpful way to think about it is this: brain anatomy is the building, but molecules are part of the wiring. Two buildings can look nothing alike and still use a similar kind of electrical switch. The octopus study suggests that MDMA may be pressing a very old switch. 

How is this different from the usual “chemical imbalance” story?

The study points away from a simple “one chemical equals one disorder” model. Dölen’s commentary says chemists may look at serotonin receptors and try to design cleaner drugs, while neurobiologists may see psychedelics as opening a window for learning (2).

This is where the study connects with psychotherapy, even though the octopus experiment itself was not a therapy study. The old chemical imbalance story says depression is just low serotonin, anxiety is just too much or too little of another chemical, and the job of medication is to correct the imbalance. That story is simple, but mental health is rarely that simple.

Dölen’s point is more subtle. Psychedelics may not be the therapy itself. They may make the brain more able to learn from the right setting, relationship, and support. That is why preparation and integration are so important in psychedelic work. If you want to read more about that clinical side, I wrote about the crucial role of preparation and integration in psilocybin therapy. 

What can this teach us about psychedelic therapy?

The main lesson is that psychedelic effects depend on biology and context. The molecule may open a door, but therapy helps shape what happens next. This is why psychedelic integration, preparation, safety, and support matter so much.

For people exploring psychedelic experiences, the octopus study is not a reason to self-medicate. It is a reason to be humble. These compounds can affect ancient and powerful systems. Their effects are not just “all in your head,” and they are not simple chemical fixes either.

In clinical work, this points toward a careful model. The medicine may create a state where new learning becomes possible. But what a person learns depends on set, setting, safety, relationship, and follow-up care. For people trying to make sense of a past psychedelic experience, psychedelic integration can help connect the experience to values, behavior, and daily life.

For people with trauma histories, this point is even more important. A window for learning can be helpful, but it can also feel overwhelming if it opens too quickly or without enough support. That is one reason trauma therapy should be grounded, paced, and relational. 

What should cautious readers take away from this research?

Cautious readers should take away wonder and restraint at the same time. The octopus-MDMA study is exciting because it suggests deep evolutionary roots for some social effects of MDMA. But it is still a small animal study, not a guide for personal drug use (1).

The best science often makes the world feel stranger and more connected. This study does that. It shows that a mostly solitary sea creature, separated from us by hundreds of millions of years, may still share a molecular doorway involved in social behavior.

At the same time, good science does not rush past limits. The study had a small sample size. It measured behavior, not inner experience. It does not tell us what octopuses felt, and it does not prove that MDMA is safe or appropriate outside approved research or medical contexts. 

Conclusion

The octopus-MDMA study matters because it asks psychedelic science to look beyond human brain anatomy and toward older molecular systems. Gül Dölen’s commentary sharpens that point: the brain may look different across species, but the molecule may still find the same lock.

If this leaves you feeling curious, cautious, or even a little amazed, that response makes sense. Octopuses already stretch our sense of what intelligence can look like. This research stretches our sense of what psychedelic science may need to study next.

I offer psychedelic integration and harm-reduction-informed therapy for people who want to think carefully about these questions, not chase hype. If you are trying to understand a past psychedelic experience, or wondering what this science could mean for your own mental health journey, I would be glad to talk it through with you. Schedule a free consultation with Jeff Jones, LPC

About the Author

This article was written by Jeff Jones, a Licensed Professional Counselor (LPC) in Texas in practice since 1999. He is a 2024 graduate of the CIIS Center for Psychedelic Therapies and Research program. With a compassionate and evidence-based approach, he helps clients navigate life's challenges and find a path toward healing.

Disclaimer

The information in this article, including discussions of psychedelic-assisted psychotherapy, is for informational purposes only. Psychedelic-assisted psychotherapy has not been approved by all regulatory agencies in the United States, and its safety and efficacy are still being established. This content is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

(1) Edsinger, E., & Dölen, G. (2018). A conserved role for serotonergic neurotransmission in mediating social behavior in octopus. Current Biology, 28(19), 3136–3142.e4.

(2) Winslow, H., & Silberberg, S. (2026, May 3). Psychonaut POV: Q&A with Gül Dölen, neurobiologist. Tricycle Day.